Alyeska Investment Group
CYTO

Alyeska Investment Group’s Altamira Therapeutics Ltd CYTO Stock Holding History

Alyeska Investment Group’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3
Closed -$1.02M – 470
2015
Q4 		$1.02M Sell
3
-1
-25% -$288K 0.01% 339
2015
Q3 		$1.02M Buy
4
+1
+33% +$383K 0.01% 386
2015
Q2 		$1.29M Buy
3
+2
+200% +$829K 0.01% 389
2015
Q1 		$614K Hold
1
– – 0.01% 462
2014
Q4 		$234K Buy
+1
New +$353K ﹤0.01% 462
2014
Q3 		– Hold
0
– – – 377

Other funds holding CYTO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Alyeska Investment Group's CYTO Position: Q1 2016 in Review

Alyeska Investment Group sold out of Altamira Therapeutics Ltd (CYTO) in Q1 2016, closing a stake of 3 shares — an estimated $1.02M sold.

Alyeska Investment Group first reported a position in CYTO in Q4 2014 and held it in 5 quarters. The position peaked at $1.29M in Q2 2015. 8 funds tracked by Wall St. Rank hold CYTO as of Q1 2016.

  • Alyeska Investment Group reported no remaining Altamira Therapeutics Ltd position as of Q1 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 3 Altamira Therapeutics Ltd shares in Q1 2016, an estimated $1.02M.
  • Alyeska Investment Group first reported a position in Altamira Therapeutics Ltd in Q4 2014 and held it in 5 quarters.
  • Alyeska Investment Group's Altamira Therapeutics Ltd position peaked at $1.29M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q1 2016.

Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.